Autolus Therapeutics plc (AUTL) Net income 2016–2025
Autolus Therapeutics plc (AUTL) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$287.5MFY2025 · since FY2016: -$12.6M → -$287.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$287.5M | -30.3% |
| FY2024 | -$220.7M | -5.9% |
| FY2023 | -$208.4M | -40.0% |
| FY2022 | -$148.8M | -4.7% |
| FY2021 | -$142.1M | -0.0% |
| FY2020 | -$142.1M | -14.7% |
| FY2019 | -$123.8M | -176.8% |
| FY2018 | -$44.8M | -126.9% |
| FY2017 | -$19.7M | -57.2% |
| FY2016 | -$12.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AUTL financial trends
AUTL RevenueAUTL Net marginAUTL Gross profitAUTL Gross marginAUTL Operating incomeAUTL Operating marginAUTL Operating cash flowAUTL Free cash flowAUTL Capital expendituresAUTL Return on equityAUTL Stock buybacksAUTL Dividends paidAUTL Total assetsAUTL Total liabilitiesAUTL Shareholders’ equityAUTL overview →